Derek LeRoith1, Geert Jan Biessels2, Susan S Braithwaite3,4, Felipe F Casanueva5, Boris Draznin6, Jeffrey B Halter7,8, Irl B Hirsch9, Marie E McDonnell10, Mark E Molitch11, M Hassan Murad12, Alan J Sinclair13. 1. Icahn School of Medicine at Mount Sinai, New York, New York. 2. University Medical Center Utrecht, Utrecht, Netherlands. 3. Presence Saint Francis Hospital, Evanston, Illinois. 4. Presence Saint Joseph Hospital, Chicago, Illinois. 5. Complejo Hospitalario Universitario de Santiago, CIBER de Fisiopatologia Obesidad y Nutricion, Instituto Salud Carlos III, Santiago de Compostela, Spain. 6. University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado. 7. University of Michigan, Ann Arbor, Michigan. 8. National University of Singapore, Singapore, Singapore. 9. University of Washington Medical Center-Roosevelt, Seattle, Washington. 10. Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 11. Northwestern University Feinberg School of Medicine, Chicago, Illinois. 12. Division of Preventive Medicine, Mayo Clinic, Rochester, Minnesota. 13. King's College, London, United Kingdom.
Abstract
OBJECTIVE: The objective is to formulate clinical practice guidelines for the treatment of diabetes in older adults. CONCLUSIONS: Diabetes, particularly type 2, is becoming more prevalent in the general population, especially in individuals over the age of 65 years. The underlying pathophysiology of the disease in these patients is exacerbated by the direct effects of aging on metabolic regulation. Similarly, aging effects interact with diabetes to accelerate the progression of many common diabetes complications. Each section in this guideline covers all aspects of the etiology and available evidence, primarily from controlled trials, on therapeutic options and outcomes in this population. The goal is to give guidance to practicing health care providers that will benefit patients with diabetes (both type 1 and type 2), paying particular attention to avoiding unnecessary and/or harmful adverse effects.
OBJECTIVE: The objective is to formulate clinical practice guidelines for the treatment of diabetes in older adults. CONCLUSIONS:Diabetes, particularly type 2, is becoming more prevalent in the general population, especially in individuals over the age of 65 years. The underlying pathophysiology of the disease in these patients is exacerbated by the direct effects of aging on metabolic regulation. Similarly, aging effects interact with diabetes to accelerate the progression of many common diabetes complications. Each section in this guideline covers all aspects of the etiology and available evidence, primarily from controlled trials, on therapeutic options and outcomes in this population. The goal is to give guidance to practicing health care providers that will benefit patients with diabetes (both type 1 and type 2), paying particular attention to avoiding unnecessary and/or harmful adverse effects.
Authors: P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service Journal: Neurology Date: 1993-04 Impact factor: 9.910
Authors: Hertzel C Gerstein; Michael E Miller; Faramarz Ismail-Beigi; Joe Largay; Charlotte McDonald; Heather A Lochnan; Gillian L Booth Journal: Lancet Date: 2014-07-31 Impact factor: 79.321
Authors: Robert A Vigersky; Stephanie J Fonda; Mary Chellappa; M Susan Walker; Nicole M Ehrhardt Journal: Diabetes Care Date: 2011-11-18 Impact factor: 19.112
Authors: Theresa A Rowe; Tiffany Brown; Ji Young Lee; Jeffrey A Linder; Mark W Friedberg; Jason N Doctor; Daniella Meeker; Jody D Ciolino; Stephen D Persell Journal: J Gen Intern Med Date: 2020-03-03 Impact factor: 5.128
Authors: Alexandra K Lee; Stephen P Juraschek; B Gwen Windham; Clare J Lee; A Richey Sharrett; Josef Coresh; Elizabeth Selvin Journal: Diabetes Care Date: 2020-07-01 Impact factor: 19.112
Authors: Joshua D Niznik; Jacob N Hunnicutt; Xinhua Zhao; Maria K Mor; Florentina Sileanu; Sherrie L Aspinall; Sydney P Springer; Mary J Ersek; Walid F Gellad; Loren J Schleiden; Joseph T Hanlon; Joshua M Thorpe; Carolyn T Thorpe Journal: J Am Geriatr Soc Date: 2020-02-17 Impact factor: 5.562